Viewing Study NCT02309320


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-01-16 @ 2:47 PM
Study NCT ID: NCT02309320
Status: COMPLETED
Last Update Posted: 2019-01-10
First Post: 2014-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Sponsor: Ablynx, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module